Advertisement

Related Videos

Peter Clark, MA, MD, FRCP: A Payer Perspective

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Advertisement

Advertisement




Oct
21
Today In Oncology
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
Starting Surveillance Colonoscopy After High-Risk Adenoma Removal When Is the Right Time
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
AI Model Based on Facial Image Analysis Estimates Biological Age and Mortality Risk in Patients With Cancer
Community Oncology Practices Bring Advances in Cancer Testing and Treatment Closer to Patients
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo